Deferred Tax Assets, Valuation Allowance in USD of PROKIDNEY CORP. from Q4 2021 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Prokidney Corp. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2021 to Q4 2024.
  • Prokidney Corp. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2024 was $6.93M, a 46.2% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)

PROKIDNEY CORP. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $6.93M -$5.96M -46.2% Dec 31, 2024 10-K 2025-03-17
Q4 2023 $12.9M +$9.56M +287% Dec 31, 2023 10-K 2025-03-17
Q4 2022 $3.33M +$2.1M +169% Dec 31, 2022 10-K 2024-03-22
Q4 2021 $1.24M Dec 31, 2021 10-K 2023-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.